GL1X · GenesisL1 explorer

MolNFT v1 · #19398 · protein

Novel covalent active site thrombin inhibitors

1QJ7: “Novel covalent active site thrombin inhibitors”. X-ray diffraction, 1 ligand (GR1), 2 pockets (best druggability 0.59). MolNFT v1 #19398 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
1QJ7
Type
protein
Length
305 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Thrombin; Hirugen
EC
3.4.21.5
UniProt
P00734, P28501
Ligands
GR1
Pockets
2 · best druggability 0.59

Structure

x-ray diffraction · 3 distinct chains · 17% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AThrombin (EC 3.4.21.5)protein3628% helix, 6% strandP00734
BThrombin (EC 3.4.21.5)protein25915% helix, 35% strandP00734
IHirugenprotein1030% helix, 0% strandP28501

Ligands and binding sites

  • GR1 · 6-carbamimidoyl-2-[5-(3-diethylcarbamoyl-phenyl)-2-hydroxy-indan-1-yl]-hexanoic acid · ligand · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12480.590.7941GR1
2910.390.7719empty

Interfaces

2 interfaces between chains.

  • A–B · 1263 Ų buried · 27 hydrogen bonds · protein-protein
  • B–I · 622 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide, 1 covalent, 1 modified (disulfide, covalent ligand, sulfation).

Compared structures

  • 1QJ7 · Novel Covalent Active Site Thrombin Inhibitors · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.